Infleqtion (NASDAQ: INFQ) CEO awarded major option and stock grants

Rhea-AI Filing Summary

Infleqtion, Inc.’s Chief Executive Officer and director Matthew John Kinsella reported multiple equity awards dated February 13, 2026. He received a stock option for 5,950,380 shares and another option for 481,727 shares, both granted at an exercise price of $0.00 per share. Some of these options vest monthly, with a portion accelerated at the closing of prior mergers, and legacy ColdQuanta options were converted into Infleqtion options on the same terms. Kinsella also reported indirect acquisitions of common stock awards of 560,327, 34,740 and 101,882 shares, held through Kinsella Investment Holdings, LLC and two John R. Kinsella family trusts over which he has voting and investment power.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kinsella Matthew John

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE CO 80027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Churchill Capital Corp X/Cayman [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		A(1)		560,327	A	$0(1)	560,327	I	See footnote(2)
Common Stock	02/13/2026		A(1)		34,740	A	$0(1)	34,740	I	See footnote(3)
Common Stock	02/13/2026		A(1)		101,882	A	$0(1)	101,882	I	See footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.9	02/13/2026		A(1)		5,950,380		(5)	06/05/2034	Common Stock	5,950,380	(6)	5,950,380	D
Stock Option (Right to Buy)	$0.9	02/13/2026		A(1)		1,889,829		(7)	06/05/2034	Common Stock	1,889,829	(6)	1,889,829	I	See footnote(2)
Stock Option (Right to Buy)	$13.22	02/13/2026		A		481,727		(8)	02/12/2036	Common Stock	481,727	$0	481,727	D

Explanation of Responses:

1. Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").

2. Held directly by Kinsella Investment Holdings, LLC. Mr. Kinsella may be deemed to beneficially own shares of Kinsella Investment Holdings, LLC by virtue of his voting power and investment power over such shares.

3. Held directly by The John R. Kinsella Children's Trust, of which the Reporting Person is co-trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Children's Trust by virtue of his voting power and investment power over such shares.

4. Held directly by The John R. Kinsella Revocable Living Trust, of which the Reporting Person is a trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Revocable Living Trust by virtue of his voting power and investment power over such shares.

5. 25% of the stock option vested and became exercisable on April 5, 2025, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. 2,275,146 of such shares accelerated and vested upon the closing of the Mergers. The option may be early exercised by the Reporting Person.

6. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.

7. Fully vested.

8. 1/48th of the shares underlying the option vest in equal monthly installments commencing on February 17, 2026, subject to the Reporting Person's continued service through each vesting date.

	/s/ Jason D. Hall, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Infleqtion (INFQ) report for Matthew John Kinsella?

Infleqtion CEO Matthew John Kinsella reported equity award acquisitions, not open-market trades. He received large stock option grants and indirect common stock awards as part of compensation and merger-related conversions, with no cash purchase price disclosed in the filing.

How many stock options were granted to the Infleqtion CEO in this Form 4?

The CEO was granted a stock option for 5,950,380 shares and a separate option for 481,727 shares. Both options have a stated exercise price of $0.00 per share, reflecting award terms rather than a market transaction price.

What are the key vesting terms of Matthew Kinsella’s Infleqtion stock options?

One option vested 25% on April 5, 2025, then vests 1/48th monthly until fully vested, with 2,275,146 shares accelerating at the merger closing. Another option vests 1/48th monthly starting February 17, 2026, conditioned on continued service.

Were legacy ColdQuanta options converted into Infleqtion (INFQ) options?

Yes. Legacy ColdQuanta stock options were automatically converted into Infleqtion options in the merger. The filing states they carry the same terms and conditions as before, preserving vesting and other award features through the corporate reorganization.

What indirect holdings are reported for the Infleqtion CEO in this Form 4?

Indirect holdings include common stock awards of 560,327, 34,740 and 101,882 shares. These are held through Kinsella Investment Holdings, LLC and two John R. Kinsella family trusts, where Matthew Kinsella has voting and investment power and may be deemed a beneficial owner.

Does this Infleqtion Form 4 show any insider share sales?

No insider sales are reported. All transactions are coded as acquisitions under transaction code “A,” representing grants or awards of stock options and common stock rather than disposals or open-market selling activity by the Infleqtion CEO or related entities.